4.4 Article

Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38

期刊

CEPHALALGIA
卷 32, 期 4, 页码 337-345

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102412439354

关键词

PACAP; neuropeptide; migraine; VIP; PAC1-receptor; Mast cells

资金

  1. Lundbeck Foundation via the Lundbeck Foundation Center for Neurovascular Signaling (LUCENS)
  2. Novo Nordisk Foundation
  3. Illum Foundation
  4. Foundation for Neurological Research
  5. Familien Hede Nielsens Foundation
  6. Candy's Foundation

向作者/读者索取更多资源

Background: Pituitary adenylate cyclase activating peptide-38 (PACAP-38) has been shown to induce migraine in migraineurs, whereas the related peptide vasoactive intestinal peptide (VIP) does not. In the present study we examine the hypothesis that PACAP-38 and its truncated version PACAP-27 but not VIP cause degranulation of mast cells in peritoneum and in dura mater. Methods: The degranulatory effects of PACAP-38, PACAP-27 and VIP were investigated by measuring the amount of N-acetyl-beta-hexosaminidase released from isolated peritoneal mast cells and from dura mater attached to the skull of the rat in vitro. In peritoneal mast cells N-truncated fragments of PACAP-38 (PACAP(6-38), PACAP(16-38) and PACAP(28-38)) were also studied. To investigate transduction pathways involved in mast cell degranulation induced by PACAP-38, PACAP-27 and VIP, the phospholipase C inhibitor U-73122 and the adenylate cyclase inhibitor SQ 22536 were used. Results: The peptides induced degranulation of isolated peritoneal mast cells of the rat with the following order of potency: PACAP-38 = PACAP(6-38) = PACAP(16-38) >> PACAP-27 = VIP = PACAP(28-38). In the dura mater we found that 10(-5) M PACAP-38 was significantly more potent in inducing mast cell degranulation than the same concentration of PACAP-27 or VIP. Inhibition of intracellular mechanisms demonstrated that PACAP-38-induced degranulation is mediated by the phospholipase C pathway. Selective blockade of the PAC1 receptor did not attenuate degranulation. Conclusion: These findings correlate with clinical studies and support the hypothesis that mast cell degranulation is involved in PACAP-induced migraine. PACAP-38 has a much stronger degranulatory effect on rat peritoneal and dural mast cells than VIP and PACAP-27. The difference in potency between PACAP-38- and PACAP-27/VIP-induced peritoneal mast cell degranulation is probably not related to the PAC1 receptor but is caused by a difference in efficacy on phospholipase C.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

The association between candidate migraine susceptibility loci and severe migraine phenotype in a clinical sample

Ann-Louise Esserlind, Anne Francke Christensen, Stacy Steinberg, Niels Grarup, Oluf Pedersen, Torben Hansen, Thomas Werge, Thomas Folkmann Hansen, Lise Lotte N. Husemoen, Allan Linneberg, Esben Budtz-Jorgensen, Maria Lurenda Westergaard, Hreinn Stefansson, Jes Olesen

CEPHALALGIA (2016)

Review Biology

Oceanic island biogeography through the lens of the general dynamic model: assessment and prospect

Michael K. Borregaard, Isabel R. Amorim, Paulo A. V. Borges, Juliano S. Cabral, Jose M. Fernandez-Palacios, Richard Field, Lawrence R. Heaney, Holger Kreft, Thomas J. Matthews, Jens M. Olesen, Jonathan Price, Francois Rigal, Manuel J. Steinbauer, Konstantinos A. Triantis, Luis Valente, Patrick Weigelt, Robert J. Whittaker

BIOLOGICAL REVIEWS (2017)

Article Clinical Neurology

Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine

Song Guo, Anne Luise Haulund Vollesen, Rikke Dyhr Hansen, Ann-Louise Esserlind, Faisal Mohammed Amin, Anne Francke Christensen, Jes Olesen, Messoud Ashina

CEPHALALGIA (2017)

Article Clinical Neurology

Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients

Song Guo, Anne Luise Haulund Vollesen, Young Bae Lee Hansen, Erik Frandsen, Malene Rohr Andersen, Faisal Mohammad Amin, Jan Fahrenkrug, Jes Olesen, Messoud Ashina

CEPHALALGIA (2017)

Article Clinical Neurology

The quality of diagnosis and management of migraine and tension-type headache in three social groups in Russia

Elena R. Lebedeva, Natalia R. Kobzeva, Denis V. Gilev, Jes Olesen

CEPHALALGIA (2017)

Article Clinical Neurology

Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine

Song Guo, Anne Francke Christensen, Marie Louise Liu, Benjamin Naveed Janjooa, Jes Olesen, Messoud Ashina

CEPHALALGIA (2017)

Article Pharmacology & Pharmacy

Effect of PGD2 on middle meningeal artery and mRNA expression profile of L-PGD2 synthase and DP receptors in trigeminovascular system and other pain processing structures in rat brain

Aysegul Sekeroglu, Julie Mie Jacobse, Inger Jansen-Olesen, Saurabh Gupta, Majid Sheykhzade, Jes Olesen, Deepak K. Bhatt

PHARMACOLOGICAL REPORTS (2017)

Correction Endocrinology & Metabolism

Large Gliadin Peptides Detected in the Pancreas of NOD and Healthy Mice following Oral Administration (vol 2016, 2424306, 2016)

Susanne W. Bruun, Knud Josefsen, Julia T. Tanassi, Ales Marek, Martin H. F. Pedersen, Ulrik Sidenius, Martin Haupt-Jorgensen, Julie C. Antvorskov, Jesper Larsen, Niels H. Heegaard, Karsten Buschard

JOURNAL OF DIABETES RESEARCH (2017)

Review Clinical Neurology

PACAP and its receptors in cranial arteries and mast cells

Inger Jansen-Olesen, Sara Hougaard Pedersen

JOURNAL OF HEADACHE AND PAIN (2018)

Article Multidisciplinary Sciences

A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain

Gordon Munro, Steffen Petersen, Inger Jansen-Olesen, Jes Olesen

SCIENTIFIC REPORTS (2018)

Article Clinical Neurology

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers

Katrine Falkenberg, Jes Olesen

JOURNAL OF HEADACHE AND PAIN (2018)

Article Clinical Neurology

Histamine and migraine revisited: mechanisms and possible drug targets

Jacob Worm, Katrine Falkenberg, Jes Olesen

JOURNAL OF HEADACHE AND PAIN (2019)

Article Pharmacology & Pharmacy

Effect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries

Anna Koldbro Hansted, Deepak Kumar Bhatt, Jes Olesen, Lars Jorn Jensen, Inger Jansen-Olesen

PHARMACOLOGICAL REPORTS (2019)

Editorial Material Clinical Neurology

Calcitonin gene-related peptide - beyond migraine prophylaxis

Jes Olesen, Messoud Ashina

NATURE REVIEWS NEUROLOGY (2019)

暂无数据